AGF increases stake in Bioalliance to 5%

At the time of going to press AGF Private Equity had increased its stake in Bioalliance Pharma to 5.06%. The company was originally listed on the Euronext's Eurolist-C in December 2005. Established in 1997, the company is a biopharmaceutical firm that develops and markets innovative drugs and predictive assays targeting cancer and infectious diseases.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Industry
• France